检索范围:
排序: 展示方式:
Pengming SUN PhD, MD , Jalid SEHOULI PhD, MD , Lihui WEI BM ,
《医学前沿(英文)》 2009年 第3卷 第3期 页码 256-264 doi: 10.1007/s11684-009-0052-3
关键词: target therapy gynecologic malignant tumors clinical trail molecular medicine
高能聚焦超声热治疗恶性肿瘤的初步探索——附78例治疗临床应用报告
何申戌,熊六林,于晋生,兰江
《中国工程科学》 1999年 第1卷 第2期 页码 62-66
目的 了解HIFU技术治疗癌瘤的临库效果和安全性。方法 应用FEP-BY01型高能聚焦超声肿瘤治疗机临床治疗78例中晚期腹腔、盆腔、多种脏器癌瘤,并将全部病例分为空腔脏器和实质脏器癌瘤两大类,按各自的标准进行疗效判断,并从疼痛、皮肤的灼伤、腔肠出血、穿孔及其它方面进行安全判断。结果 空腔脏器肿瘤32例,出院时65.6%肿瘤脱落消失,34.4%萎缩。实质脏器癌瘤46例;治疗后15.6%显著疗效,80.4%有效,无效4.3%(因肋骨阻挡),与放化疗合用可加速肿瘤脱落或萎缩。结论 HIFU技术对控制肿瘤有肯定疗效,并且安全可靠,值得推广应用;其相关医学基础研究须尽快开展。
Bin Yang, Yan Yu, Jing Chen, Yan Zhang, Ye Yin, Nan Yu, Ge Chen, Shifei Zhu, Haiyan Huang, Yongqun Yuan, Jihui Ai, Xinyu Wang, Kezhen Li
《医学前沿(英文)》 2018年 第12卷 第5期 页码 509-517 doi: 10.1007/s11684-017-0554-3
This study was performed to evaluate the oncological and reproductive outcomes of childbearing-age women treated with fertility-sparing surgery (FSS) for non-epithelial ovarian tumors in China. One hundred and forty eight non-epithelial ovarian tumor women treated with FSS between January 1, 2000 and August 31, 2015 from two medical centers in China were identified. Progression-free survival (PFS) was 88.5%, whereas overall survival (OS) was 93.9%. Univariate analysis suggested that delivery after treatment is related to PFS (P=0.023), whereas histology significantly influenced OS. Cox regression analysis suggested that only histology was associated with PFS and OS (P<0.05). Among the 129 women who completed adjuvant chemotherapy (ACT), none developed amenorrhea. Among the 44 women who desired pregnancy, 35 (79.5%) successfully had 51 gestations including 35 live births without birth defects. Non-epithelial ovarian tumors can achieve fulfilling prognosis after FSS and chemotherapy. Histology might be the only independent prognostic factor for PFS and OS. FSS followed by ACT appeared to have little or no effect on fertility. Meanwhile, postoperative pregnancy did not increase the PFS or OS. Use of gonadotropin-releasing hormone agonist was not beneficial for fertility.
关键词: malignant germ cell tumors ovarian sex cord-stromal tumors fertility-sparing surgery prognosis fertility
Rare tumors: a blue ocean of investigation
《医学前沿(英文)》 2023年 第17卷 第2期 页码 220-230 doi: 10.1007/s11684-023-0984-z
关键词: rare tumors diagnosis flowchart treatment strategy clinical trials recommendation
Progress on molecular biomarkers and classification of malignant gliomas
null
《医学前沿(英文)》 2013年 第7卷 第2期 页码 150-156 doi: 10.1007/s11684-013-0267-1
Gliomas are the most common primary intracranial tumors in adults. Anaplastic gliomas (WHO grade III) and glioblastomas (WHO grade IV) represent the major groups of malignant gliomas in the brain. Several diagnostic, predictive, and prognostic biomarkers for malignant gliomas have been reported over the last few decades, and these markers have made great contributions to the accuracy of diagnosis, therapeutic decision making, and prognosis of patients. However, heterogeneity in patient outcomes may still be observed, which highlights the insufficiency of a classification system based purely on histopathology. Great efforts have been made to incorporate new information about the molecular landscape of gliomas into novel classifications that may potentially guide treatment. In this review, we summarize three distinctive biomarkers, three most commonly altered pathways, and three classifications based on microarray data in malignant gliomas.
关键词: malignant glioma molecular biomarker IDH1 MGMT molecular classification
Immunological effects of nano-enabled hyperthermia for solid tumors: opportunity and challenge
《化学科学与工程前沿(英文)》 2022年 第16卷 第3期 页码 333-344 doi: 10.1007/s11705-021-2059-5
关键词: nano-enabled hyperthermia immunogenic cell death heterogeneous immunological landscape tumor microenvironment
Minimal residual disease in solid tumors: an overview
《医学前沿(英文)》 2023年 第17卷 第4期 页码 649-674 doi: 10.1007/s11684-023-1018-6
关键词: MRD solid tumor CTC ctDNA
ZHU Lidong, CHEN Xiaoping
《医学前沿(英文)》 2007年 第1卷 第4期 页码 364-368 doi: 10.1007/s11684-007-0070-y
《医学前沿(英文)》 页码 805-822 doi: 10.1007/s11684-023-1025-7
关键词: CTLA-4 PD-1 PD-L1 immune checkpoint blockade (ICB) metabolic reprogramming combined tumor therapeutic strategies
null
《医学前沿(英文)》 2017年 第11卷 第1期 页码 120-128 doi: 10.1007/s11684-017-0501-3
Norepinephrine transporter (NET) transfection leads to significant uptake of iodine-131-labeled metaiodobenzylguanidine (131I-MIBG) in non-neuroendocrine tumors. However, the use of 131I-MIBG is limited by its short retention time in target cells. To prolong the retention of 131I-MIBG in target cells, we infected hepatocarcinoma (HepG2) cells with Lentivirus-encoding human NET and vesicular monoamine transporter 2 (VMAT2) genes to obtain NET-expressing, NET-VMAT2-coexpressing, and negative-control cell lines. We evaluated the uptake and efflux of 131I-MIBG both in vitro and in vivo in mice bearing transfected tumors. NET-expressing and NET-VMAT2-coexpressing cells respectively showed 2.24 and 2.22 times higher 131I-MIBG uptake than controls. Two hours after removal of 131I-MIBG-containing medium, 25.4% efflux was observed in NET-VMAT2-coexpressing cells and 38.6% in NET-expressing cells. In vivo experiments were performed in nude mice bearing transfected tumors; results revealed that NET-VMAT2-coexpressing tumors had longer 131I-MIBG retention time than NET-expressing tumors. Meanwhile, NET-VMAT2-coexpressing and NET-expressing tumors displayed 0.54% and 0.19%, respectively, of the injected dose per gram of tissue 24 h after 131I-MIBG administration. Cotransfection of HepG2 cells with NET and VMAT2resulted in increased 131I-MIBG uptake and retention. However, the degree of increase was insufficient to be therapeutically effective in target cells.
关键词: norepinephrine transporter vesicular monoamine transporter 2 -MIBG gene therapy lentivirus vector
《医学前沿(英文)》 页码 907-923 doi: 10.1007/s11684-023-1009-7
LIANG Yumei, LI Xianghong, LU Youyong, LV Yali, ZHONG Mei, PU Xiaolu, LI Wenmei
《医学前沿(英文)》 2008年 第2卷 第1期 页码 87-94 doi: 10.1007/s11684-008-0016-z
Potential indicators predict progress after surgical resection of gastrointestinal stromal tumors
null
《医学前沿(英文)》 2012年 第6卷 第3期 页码 317-321 doi: 10.1007/s11684-012-0203-9
In order to find out the potential indicators predicting prognosis of malignant gastrointestinal stromal tumors (GISTs) after surgical resection, we collected clinical records of 80 patients with malignant GISTs. Tumor location, size, mitotic index, necrosis were compared with the prognosis of malignant GISTs by Kaplan-Meier method and log-rank test. After a median follow-up of 844 days (52–2 145), we found that as National Institutes of Health suggested, tumors with intermediate risk had more favorable prognosis than that with high risk. Their 3-year survival rate were 65.3% and 41.3%, respectively (P<0.001). Moreover, tumor size and mitotic index were associated with free survival. The 3-year survival rate for patients with tumor size≤10 cm and>10 cm were 62.3% and 41.8%, respectively (P = 0.002), Tumors with mitotic index≤5/50 HPF had a higher 3-year survival rate than tumors with mitotic index>5/50 HPF (67.1% versus 40.7%, P = 0.005). The presence of necrosis was directly related to the malignant behavior. The 3-year survival rate for presence and absence necrosis were 50.8% and 64.8% (P = 0.008). From the present study, we can conclude that besides tumors size and mitotic index, tumor location and necrosis also influence on the long-term survival of patient with malignant GISTs after surgical resection.
Minggen YANG, Xiaokun ZHAO
《医学前沿(英文)》 2009年 第3卷 第2期 页码 191-196 doi: 10.1007/s11684-009-0026-5
JIANG Yuan, TIAN Xuehong, YUAN Jie, JIN Yuemei, TAN Yusong
《医学前沿(英文)》 2007年 第1卷 第4期 页码 398-400 doi: 10.1007/s11684-007-0077-4
关键词: anticarcinogenic microvessel density malignant potency muscle uterine leiomyosarcoma
标题 作者 时间 类型 操作
Molecular targeted therapy of gynecological malignant tumors: the development and challenge, from laboratory
Pengming SUN PhD, MD , Jalid SEHOULI PhD, MD , Lihui WEI BM ,
期刊论文
Possibility of women treated with fertility-sparing surgery for non-epithelial ovarian tumors to safely
Bin Yang, Yan Yu, Jing Chen, Yan Zhang, Ye Yin, Nan Yu, Ge Chen, Shifei Zhu, Haiyan Huang, Yongqun Yuan, Jihui Ai, Xinyu Wang, Kezhen Li
期刊论文
Change and significance of T-cell subsets and TNF-α in patients with advanced malignant obstructive jaundice
ZHU Lidong, CHEN Xiaoping
期刊论文
Metabolic interventions combined with CTLA-4 and PD-1/PD-L1 blockade for the treatment of tumors: mechanisms
期刊论文
monoamine transporter 2 genes for increased retention of metaiodobenzylguanidine labeled with iodine 131 in malignant
null
期刊论文
High frequency of alternative splicing variants of the oncogene in neuroendocrine tumors of the pancreas
期刊论文
Prognostic significance of clinicopathologic parameters in gastrointestinal stromal tumors: a study of
LIANG Yumei, LI Xianghong, LU Youyong, LV Yali, ZHONG Mei, PU Xiaolu, LI Wenmei
期刊论文
Potential indicators predict progress after surgical resection of gastrointestinal stromal tumors
null
期刊论文
Retrospective study of the efficacy and complication of thoracoabdominal incision for nephrectomy: a comparison with flank approach
Minggen YANG, Xiaokun ZHAO
期刊论文